Semler Scientific Stock News

Semler has delivered 17% returns since we last wrote about it, but we are now looking to revise our stance. SMLR's Q3 earnings which came out yesterday was impressive on the headline front, but revenue attrition persists and will likely worsen in Q4. The onus now will shift to cash conversion, which SMLR continues to facilitate, but the pronounced degree of OPEX contractions looks to be fading.

The medical device company has made a peculiar bet on a popular cryptocurrency.

Semler Scientific, Inc. (NASDAQ:SMLR ) Q3 2024 Earnings Conference Call November 4, 2024 4:30 PM ET Company Participants Doug Murphy-Chutorian - Chief Executive Officer Eric Semler - Chairman Jennifer Oliva Herrington - Chief Operating Officer Renae Cormier - Chief Financial Officer Conference Call Participants Operator Good afternoon, everyone, and welcome to the Semler Scientific Third Quarte...

SANTA CLARA, Calif. , Nov. 4, 2024 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a pioneer in developing and marketing technology products and services to healthcare providers to combat chronic diseases, today reported financial results for the third quarter ended September 30, 2024.

SANTA CLARA, Calif. , Oct. 21, 2024 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a pioneer in developing and marketing technology products and services to healthcare providers to combat chronic diseases, today announced that it will report financial results for the third quarter and nine months ended September 30, 2024, as well as provide an update on its Bitcoin holdings after the c...

SANTA CLARA, Calif. , Aug. 26, 2024 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a pioneer in developing and marketing technology products and services to healthcare providers to combat chronic diseases, today announced that it has purchased an additional 83 bitcoins for $5.0 million in cash, inclusive of fees and expenses.

Semler Scientific, Inc. (NASDAQ:SMLR ) Q2 2024 Earnings Conference Call August 5, 2024 4:30 PM ET Company Participants Doug Murphy-Chutorian - Chief Executive Officer Eric Semler - Chairman Jennifer Oliva Herrington - Chief Operating Officer Renae Cormier - Chief Financial Officer Conference Call Participants Operator Good afternoon, and welcome to the Semler Scientific 2024 Second Quarter Fina...

SANTA CLARA, Calif. , Aug. 5, 2024 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a pioneer in developing and marketing technology products and services to healthcare providers to combat chronic diseases, today reported financial results for the second quarter ended June 30, 2024.